Amid the shortage of the anti-viral drug Remdesivir in the wake of spike in COVID-19 infections in the country, seven major pharmaceutical companies have reduced the maximum retail price (MRP) of the drug on the intervention of the Union government.

The announcement comes days after the Central government held a meeting with all existing manufacturers of the drug and other stakeholders in order to discuss steps taken to increase production and supply and reduce prices of Remdesivir.